EPG5 and Alzheimer disease: Furthermore, 7 single-nucleotide polymorphisms (SNPs) in EPG5 have been associated with AD, and 8 SNPs have been associated with an earlier age of onset of AD [161], suggesting that alterations in EPG5’s expression may confer susceptibility to neurodegeneration.